PharmX TechnologiesASX:PHX 40 OCF Yield % is 1.18 as of Jun. 29, 2026, which is 67% below its 10-year median of 3.60. GuruFocus rates ASX:PHX with a GF Score™ of 40/100 and a GF Value™ of A$0.07 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 683 Healthcare Providers & Services companies, PharmX Technologies ranks worse than 66.33% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for PharmX Technologies's OCF Yield % or its related term are showing as below:
ASX:PHX'
s OCF Yield % Range Over the Past 10 Years
Min: -15.44 Med: 3.6 Max: 67.88
Current: 1.18
During the past 13 years, the highest OCF Yield % of PharmX Technologies was 67.88%. The lowest was -15.44%. And the median was 3.60%.
ASX:PHX's OCF Yield % is ranked worse than 66.33% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 5.51
vs ASX:PHX: 1.18
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
PharmX Technologies OCF Yield % Related Terms
PharmX Technologies OCF Yield % Historical Data
* Premium members only.
The historical data trend for PharmX Technologies's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:PHX vs VEEV, BTSG, TEM: OCF Yield % Comparison
For the Health Information Services subindustry, PharmX Technologies's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmX Technologies OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's OCF Yield % distribution charts can be found below:
* The bar in red indicates where PharmX Technologies's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmX Technologies (ASX:PHX) has a OCF Yield % of 1.18 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PharmX Technologies and its competitors. This is 67% below median its historical median of 3.60. According to the industry distribution chart, PharmX Technologies ranks #453 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 66.3%.
Is PharmX Technologies' OCF Yield % too high?
PharmX Technologies' current OCF Yield % of 1.18 is 67% below median its 10-year median of 3.60. The Healthcare Providers & Services industry median OCF Yield % is 5.51. PharmX Technologies' value of 1.18 is 78.6% below this industry median. Based on the distribution chart, PharmX Technologies ranks #453 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PharmX Technologies has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PharmX Technologies' OCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, PharmX Technologies ranks #453 out of 683 companies for OCF Yield %. This places PharmX Technologies in the lower half of its industry. The industry median OCF Yield % is 5.51. PharmX Technologies' value of 1.18 is 78.6% below this benchmark. While the company's 10-year median is 3.60 vs. the industry median of 5.51, PharmX Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.51, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmX Technologies's current OCF Yield % of 1.18 is 78.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PharmX Technologies and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmX Technologies's current OCF Yield % is 1.18, which is 67% below median its own 10-year median of 3.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmX Technologies stock overvalued right now?
Based on GuruFocus' analysis, PharmX Technologies (ASX:PHX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.07, compared to a current price of A$0.13 — trading 85.7% above its estimated fair value. The current OCF Yield % is 1.18, which is 67% below median its 10-year median of 3.60 and 78.6% below the Healthcare Providers & Services industry median of 5.51. PharmX Technologies' overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For PharmX Technologies (ASX:PHX), the current OCF Yield % is 1.18 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PharmX Technologies (ASX:PHX) Overvalued in 2026?
Based on GuruFocus' analysis, PharmX Technologies stock appears to be overvalued.
The current stock price of A$0.13 is trading 85.7% above its estimated GF Value™ of A$0.07.
GuruFocus considers PharmX Technologies to be Significantly Overvalued.
Key valuation signals for ASX:PHX:
OCF Yield %: 1.18 (67% below median its 10-year median of 3.60)
GF Value™: A$0.07 vs. price of A$0.13 (85.7% above fair value)
Industry Position: 78.6% below the Healthcare Providers & Services median (#453 of 683)
No single metric tells the full story. See the ASX:PHX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.
40GF Score
Get the complete analysis for ASX:PHX
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PHX has been successfully added to your 
